Zota Health Care Limited (NSE:ZOTA)
India · Delayed Price · Currency is INR 1,255.20
+29.80 (2.43%)
Jul 31, 2026, 3:29 PM IST
Zota Health Care Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 5,387 | 5,387 | 2,930 | 1,805 | 1,408 | 1,313 |
Revenue Growth | 83.86% | 83.86% | 62.32% | 28.23% | 7.22% | 22.47% |
Gross Profit Gross Profit Growth | 3,247 | 3,247 | 1,545 | 833.24 | 572.41 | 445.41 |
Operating Income Operating Income Growth | -639.13 | -639.13 | -479.32 | -125.31 | -38.27 | 112.05 |
Net Income Net Income Growth | -739.36 | -739.36 | -563.98 | -143.48 | -57.73 | 89.08 |
Earnings Per Share EPS Growth | -22.46 | -22.46 | -20.68 | -5.59 | -2.29 | 3.58 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 955.74 | 955.74 | 36.19 | 10.05 | 11.15 | 22.99 |
Total Debt Total Debt Growth | 2,704 | 2,704 | 1,396 | 952.85 | 451.22 | 149.01 |
Net Cash (Debt) Net Cash Growth | -1,749 | -1,749 | -1,360 | -942.8 | -440.07 | -126.01 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -53.12 | -53.12 | -49.87 | -36.76 | -17.49 | -5.06 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -844.25 | -844.25 | -499.64 | -59.84 | -20.06 | 133.32 |
Capital Expenditures CapEx Growth | -1,129 | -1,129 | -459.78 | -167.1 | -124.99 | -32.48 |
Free Cash Flow Free Cash Flow Growth | -1,974 | -1,974 | -959.42 | -226.94 | -145.05 | 100.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 60.28% | 60.28% | 52.73% | 46.17% | 40.67% | 33.93% |
Operating Margin | -11.87% | -11.87% | -16.36% | -6.94% | -2.72% | 8.54% |
Pretax Margin | -14.82% | -14.82% | -19.68% | -8.96% | -3.33% | 9.47% |
Profit Margin | -13.73% | -13.73% | -19.25% | -7.95% | -4.10% | 6.79% |
FCF Margin | -36.64% | -36.64% | -32.75% | -12.57% | -10.31% | 7.68% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.500 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | -33.33% | 50.00% |
Dividend Yield | 0.08% | 0.09% | 0.12% | 0.21% | 0.36% | 0.51% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | 84.06 |
P/FCF Ratio | - | - | - | - | - | 74.25 |
PS Ratio | 8.23 | 6.68 | 6.92 | 6.62 | 5.04 | 5.70 |